Ovid Therapeutics Statistics
Total Valuation
OVID has a market cap or net worth of $221.31 million. The enterprise value is $209.47 million.
Important Dates
The next estimated earnings date is Wednesday, March 11, 2026, before market open.
| Earnings Date | Mar 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
OVID has 130.18 million shares outstanding. The number of shares has increased by 0.35% in one year.
| Current Share Class | 130.18M |
| Shares Outstanding | 130.18M |
| Shares Change (YoY) | +0.35% |
| Shares Change (QoQ) | +0.01% |
| Owned by Insiders (%) | 3.07% |
| Owned by Institutions (%) | 34.05% |
| Float | 99.54M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 33.48 |
| Forward PS | 631.97 |
| PB Ratio | 2.71 |
| P/TBV Ratio | 4.95 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 31.69 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.24, with a Debt / Equity ratio of 0.31.
| Current Ratio | 4.24 |
| Quick Ratio | 3.77 |
| Debt / Equity | 0.31 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -18.73 |
Financial Efficiency
Return on equity (ROE) is -60.06% and return on invested capital (ROIC) is -121.33%.
| Return on Equity (ROE) | -60.06% |
| Return on Assets (ROA) | -29.33% |
| Return on Invested Capital (ROIC) | -121.33% |
| Return on Capital Employed (ROCE) | -68.48% |
| Weighted Average Cost of Capital (WACC) | 6.03% |
| Revenue Per Employee | $287,391 |
| Profits Per Employee | -$1.56M |
| Employee Count | 23 |
| Asset Turnover | 0.08 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +220.76% in the last 52 weeks. The beta is 0.26, so OVID's price volatility has been lower than the market average.
| Beta (5Y) | 0.26 |
| 52-Week Price Change | +220.76% |
| 50-Day Moving Average | 1.61 |
| 200-Day Moving Average | 1.15 |
| Relative Strength Index (RSI) | 58.84 |
| Average Volume (20 Days) | 1,101,150 |
Short Selling Information
The latest short interest is 5.20 million, so 4.00% of the outstanding shares have been sold short.
| Short Interest | 5.20M |
| Short Previous Month | 4.84M |
| Short % of Shares Out | 4.00% |
| Short % of Float | 5.23% |
| Short Ratio (days to cover) | 3.33 |
Income Statement
In the last 12 months, OVID had revenue of $6.61 million and -$35.87 million in losses. Loss per share was -$0.50.
| Revenue | 6.61M |
| Gross Profit | 6.61M |
| Operating Income | -39.07M |
| Pretax Income | -36.33M |
| Net Income | -35.87M |
| EBITDA | -38.65M |
| EBIT | -39.07M |
| Loss Per Share | -$0.50 |
Full Income StatementBalance Sheet
The company has $25.60 million in cash and $13.76 million in debt, with a net cash position of $11.84 million or $0.09 per share.
| Cash & Cash Equivalents | 25.60M |
| Total Debt | 13.76M |
| Net Cash | 11.84M |
| Net Cash Per Share | $0.09 |
| Equity (Book Value) | 44.70M |
| Book Value Per Share | 0.63 |
| Working Capital | 22.03M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$37.93 million and capital expenditures -$22,000, giving a free cash flow of -$37.96 million.
| Operating Cash Flow | -37.93M |
| Capital Expenditures | -22,000 |
| Free Cash Flow | -37.96M |
| FCF Per Share | -$0.29 |
Full Cash Flow StatementMargins
| Gross Margin | 100.00% |
| Operating Margin | -591.04% |
| Pretax Margin | -549.62% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
OVID does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.35% |
| Shareholder Yield | -0.35% |
| Earnings Yield | -16.21% |
| FCF Yield | -17.15% |
Analyst Forecast
The average price target for OVID is $3.40, which is 100.00% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $3.40 |
| Price Target Difference | 100.00% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 119.05% |
| EPS Growth Forecast (5Y) | 5.13% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
OVID has an Altman Z-Score of -7.14 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -7.14 |
| Piotroski F-Score | 1 |
